글로벌 오토코이드 및 관련 약물 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 오토코이드 및 관련 약물 시장

글로벌 오토코이드 및 관련 약물 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 위에 언급된 연구 예측 기간 동안 3.80%의 건강한 CAGR로 성장하고 있다고 분석합니다.

오타코이드는 유기 물질로, 유기체의 한 부분에서 합성되어 혈액이나 림프계를 통해 유기체의 다른 부분으로 운반되어 생리적 효과를 발휘하는 호르몬입니다. 이용 가능한 오타코이드의 종류는 아민 히스타민과 5-하이드록시트립타민, 지질 프로스타글란딘, 펩타이드 안지오텐신입니다. 오타코이드의 약리적 작용은 신체의 중요한 시스템에서 관찰됩니다. 순환계 에서 동맥은 5-하이드록시트립타민의 직접적인 발병으로 수축되고 확장됩니다. 호흡계 에서 과 호흡이 일어납니다. 5-하이드록시트립타민은 혈소판의 모양에 형태학적 변화를 일으킵니다. 5-하이드록시트립타민 작용제는 우울증을 억제하기 위해 플루옥세틴으로 치료적으로 사용되고 5-하이드록시트립타민 길항제는 메스꺼움의 치료적 지표로 돌라세트론으로 사용됩니다. 다가오는 미래에는 자율신경계의 오토코이드 체계적 협력을 이용하여 다양한 주파수 에너지 가열 형태의 무선 주파수에 대한 심혈관계의 반응을 연구할 수 있을 것입니다.

The rise in number of patients suffering from chronic diseases, rise in geriatric population, increased investment by Research and Development for autacoids as potential immunomodulators, production of novel drugs, increasing awareness about use of lipid autacoids for treatment of lipid metabolic disease are the key factors driving the market growth. However, the presence of stringent regulations by FDA for the drug approval, rise in product recalls, poor reimbursement framework, lack of awareness about the use of autacoids among the patient population are the restraints which can hamper the market growth. The presence of untapped opportunities , increase in number of upcoming healthcare infrastructure and testing centers  and strategic initiatives by market players are the opportunities which are expected to boost the market growth. The challenges which are likely to tamper the market growth are the use of alternatives and the accessibility of off-label drug usage and strict supervisory maintenance for drug approval.

This autacoids and related drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Autacoids and Related Drugs Market Scope and Market Size

The Autacoids and Related Drugs market is segmented on the basis of Route of type, drug type, polypeptides, decarboxylated amino acids, route of administration, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of route of type, the autacoids and related drugs market is segmented into amines- histamines and 5-Hydroxytryptamine, lipids-prostaglandins and peptide-angiotensin.
• On the basis of drug type, the autacoids and related drugs market is segmented into lipid-derived autacoids, polypeptide autacoids, drugs related to endothelium-derived autacoids, and biogenic amines.
• On the basis of polypeptides, the autacoids and related drugs market is segmented into vasopressin, vasoactive intestinal polypeptide, plasma kinin.
• On the basis of decarboxylated amino acids, the autacoids and related drugs market is segmented into serotonin and histamine.
• On the basis of route of administration, the autacoids and related drugs market is segmented into oral and parenteral.
• On the basis of distribution channel, the autacoids and related drugs market has also been segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Autacoids and Related Drugs Market Country Level Analysis

Autacoids and Related Drugs market is analyzed and market size information is provided by country, type, drug type, polypeptides, decarboxylated amino acids, route of administration, and distribution channel as referenced above.

The countries covered in the Autacoids and Related Drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the increased count in number of local ailments, increased safety and implementation of drugs, rise in research and development initiatives. Asia-Pacific is expected to account for the fastest growing market due to rise in awareness about autacoids and other related drugs, strategic initiatives by market players, increased necessity for medical community to focus on the effects of chronic pain in patients.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Autacoids and Related Drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Autacoids and Related Drugs Market Share Analysis

Autacoids and Related Drugs 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 Autacoids and Related Drugs 시장과 관련된 회사의 초점에만 관련이 있습니다.

Autacoids and Related Drugs 시장에서 다루는 주요 업체는 BEDFORD LABORATORIES, Bristol-Myers Squibb Company, APP Pharma, Abbott, Sanofi, CHATTEM, AstraZeneca, Hospira 등 국내 및 글로벌 업체입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-60403